By: Amanda Sheppeard
Depemokimab has won TGA approval for severe eosinophilic asthma, expanding biologic treatment options for eligible Australians.
Amanda Sheppeard is an Associate Editor/Senior Journalist at various esteemed publications. She specializes in medicine and healthcare, covering a range of topics including consumer health, mental health, public health, and digital health, with a particular focus on alternative medicine and wellness. Amanda's work has been featured in the Cairns Post, The Daily Telegraph, The Advertiser Foundation, REA Group Ltd, The Weekly Times, North Queensland News, The NT News, Health Services Daily, and The Medical Republic.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Australia (National)


Not enough data
Amanda's coverage mainly focuses on healthcare and government announcements in Australia. She appears to be interested in articles that cover medical updates, government policies related to healthcare, and health and wellbeing topics.
Given her focus on national issues within the Australian healthcare landscape, she is likely to respond well to pitches from experts who can provide insights into local health policy changes, medical breakthroughs or challenges within the country's healthcare infrastructure.
As Amanda covers a wide range of topics within the Healthcare & Pharmaceutical theme with a significant emphasis on Government & Politics as well as Health & Wellbeing, consider tailoring your pitch specifically around these themes for increased relevance.
This information evolves through artificial intelligence and human feedback. Improve this profile .